These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38574630)
41. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. Wang Y; Li Y; He H; Wang F Gene; 2019 Dec; 720():144099. PubMed ID: 31479715 [TBL] [Abstract][Full Text] [Related]
42. ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells. Zhao L; Wu X; Zhang Z; Fang L; Yang B; Li Y Cancer Sci; 2023 Jun; 114(6):2650-2663. PubMed ID: 36846943 [TBL] [Abstract][Full Text] [Related]
43. Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC). Cui D; Feng Y; Qian R Bioengineered; 2021 Dec; 12(1):8435-8446. PubMed ID: 34694211 [TBL] [Abstract][Full Text] [Related]
44. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922 [TBL] [Abstract][Full Text] [Related]
45. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer. Xie FW; Liu JC Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487 [TBL] [Abstract][Full Text] [Related]
46. hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox. Qu M; Jin Z; Xu Y; Sun W; Luo Y; Zhang N; Huang Z; Han L; Gong Y; Xie C Genet Test Mol Biomarkers; 2023 Dec; 27(12):393-405. PubMed ID: 38156905 [No Abstract] [Full Text] [Related]
47. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells. Geng Q; Li Z; Li X; Wu Y; Chen N J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335 [TBL] [Abstract][Full Text] [Related]
48. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway. Guo Z; Ye H; Zheng X; Yin W; He J J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116 [TBL] [Abstract][Full Text] [Related]
49. Exosomes derived from bone mesenchymal stem cells attenuate myocardial fibrosis both in vivo and in vitro via autophagy activation: the key role of miR-199a-3p/mTOR pathway. Fan C; Wang Q; Chen Y; Ye T; Fan Y Hum Cell; 2022 May; 35(3):817-835. PubMed ID: 35190954 [TBL] [Abstract][Full Text] [Related]
50. Extracellular Vesicles From Bone Marrow Mesenchymal Stem Cells Inhibit Apoptosis and Autophagy of Ischemia-hypoxia Cardiomyocyte Line Wang W; Peng X; Zhao L; Zhao H; Gu Q Curr Stem Cell Res Ther; 2023; 18(2):247-259. PubMed ID: 35507744 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Sun B; Hu N; Cong D; Chen K; Li J Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345 [TBL] [Abstract][Full Text] [Related]
52. Extracellular vesicles-encapsulated microRNA-29b-3p from bone marrow-derived mesenchymal stem cells promotes fracture healing via modulation of the PTEN/PI3K/AKT axis. Yang J; Gao J; Gao F; Zhao Y; Deng B; Mu X; Xu L Exp Cell Res; 2022 Mar; 412(2):113026. PubMed ID: 35026284 [TBL] [Abstract][Full Text] [Related]
53. VEGFR affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer. Hui K; Dong C; Hu C; Li J; Yan D; Jiang X Funct Integr Genomics; 2024 Feb; 24(2):31. PubMed ID: 38363405 [TBL] [Abstract][Full Text] [Related]
54. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
55. Bone marrow mesenchymal stem cell-derived exosomal microRNA-124-3p attenuates neurological damage in spinal cord ischemia-reperfusion injury by downregulating Ern1 and promoting M2 macrophage polarization. Li R; Zhao K; Ruan Q; Meng C; Yin F Arthritis Res Ther; 2020 Apr; 22(1):75. PubMed ID: 32272965 [TBL] [Abstract][Full Text] [Related]
56. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554 [TBL] [Abstract][Full Text] [Related]
57. Knockdown of LINC00473 promotes radiosensitivity of non-small cell lung cancer cells via sponging miR-513a-3p. Qin P; Li Y; Liu J; Wang N Free Radic Res; 2020 Oct; 54(10):756-764. PubMed ID: 33103510 [TBL] [Abstract][Full Text] [Related]
58. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways. Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688 [TBL] [Abstract][Full Text] [Related]
59. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer. Liu JQ; Feng YH; Zeng S; Zhong MZ Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854 [TBL] [Abstract][Full Text] [Related]
60. Mouse mesenchymal stem cell-derived exosomal miR-466f-3p reverses EMT process through inhibiting AKT/GSK3β pathway via c-MET in radiation-induced lung injury. Li Y; Shen Z; Jiang X; Wang Y; Yang Z; Mao Y; Wu Z; Li G; Chen H J Exp Clin Cancer Res; 2022 Apr; 41(1):128. PubMed ID: 35392967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]